SGHT

Insider trade Sale by Bauerlein Alison (Chief Operating Officer)

13d ago

News UnitedHealthcare Adds Sight Sciences OMNI System To Covered Glaucoma Surgery Procedures

14d ago

News Sight Sciences signals $83M-$89M 2026 revenue outlook while targeting $6M-$8M dry eye sales

26d ago

SEC filing SGHT Wins $55.4M Verdict vs Alcon, 10% Royalty on Hydrus Revenue

40d ago

Insider trade Sale by Jeremy B. Hayden (Chief Legal Officer)

53d ago

Insider trade Sale by James Rodberg (Chief Financial Officer)

53d ago

News Sight Sciences outlines $82M–$88M 2026 revenue target while expanding interventional dry eye strategy

89d ago

SEC filing SGHT Reports $20.4M Q4 Rev, $77.4M FY Rev, 7% QoQ Growth, 86% Gross Margin, $92M Cash, 13% OpEx Cut, 2026 Guidance

89d ago

Insider trade Sale by James Rodberg

104d ago

Insider trade Sale by Badawi Paul

104d ago

Insider trade Sale by Jeremy B. Hayden

104d ago

Insider trade Sale by David Badawi

104d ago

News From REITs to Retail: Small caps with the longest runs at bullish Quant ratings

113d ago

SEC filing Entry into a Material Definitive Agreement

118d ago

News U.S. Futures Fall, Safe-Havens Surge as Fed Chair Powell Under Investigation

141d ago

Scanner Unusual volume (z=2.7)

160d ago

Scanner Unusual volume (z=2.6)

162d ago

Scanner Unusual volume (z=2.6)

163d ago

Scanner Unusual volume (z=2.6)

164d ago

Scanner Unusual volume (z=4.2)

168d ago